treatment [ftcn]
Dyslipoproteinemia [patf]
Metabolic syndrome [dsyn]
Metabolic syndrome [dsyn]
Cluster [idcn]
Metabolic Disorders [dsyn]
Promote [acty]
Atherosclerosis [dsyn]
Cardiovascular disease [dsyn]
Metabolic syndrome [dsyn]
Characterized [acty]
Atherogenesis [patf]
Dyslipidaemia [dsyn]
elevated triglycerides [fndg]
Increased [qnco]
Small [qnco]
Dense [qlco]
Low-Density Lipoproteins [aapp, bacs, lipd]
Decreased [qnco]
High Density Lipoproteins [aapp, bacs, lipd]
Hypertension [dsyn]
Insulin Resistance [patf]
Obesity [dsyn]
Decrease [qlco]
cardiovascular events [fndg]
Decreasing [qlco]
Body Weight [orga]
ingesting [biof]
Healthy diet [topp]
Increasing [ftcn]
Physical activity [dora]
Cessation [acty]
Smoking [inbe]
Managing [ocac]
Dyslipidaemia [dsyn]
Recommended [idcn]
Pharmacological Treatment [topp]
Dyslipidaemia [dsyn]
Based [ftcn]
Drug [phsu]
Class [inpr]
Cholesterol, LDL [bacs, strd]
lowering [spco]
Statins [orch, phsu]
Triglyceride [bacs, lipd]
lowering [spco]
Fibrates [orch, phsu]
Primary [qlco]
secondary [neop]
prevention trials [resa]
Heart disease [dsyn]
coronary artery disease [dsyn]
coronary [bpoc]
Events [evnt]
Percent [qnco]
Statins [orch, phsu]
cholesterol levels [lbpr]
Competitive inhibition [moft]
HMG CoA Reductase [aapp, enzy]
Fasting [fndg]
Postprandial [tmco]
Triglyceride level [lbtr]
Fibrates [orch, phsu]
Fasting [fndg]
Postprandial [tmco]
Lipemia [fndg]
Shift [ftcn]
distribution [idcn]
LDL particle [celc]
Dense [qlco]
particles [chvs]
Cholesterol, HDL [bacs, lipd]
Fibrates [orch, phsu]
Address [inpr]
Components [mnob]
Metabolic syndrome [dsyn]
diabetic [fndg]
Dyslipidaemia [dsyn]
Study [mnob]
Needed [qlco]
Definite [qlco]
Differential [qlco]
therapy [ftcn]
Lipid [lipd]
lowering [spco]
Based [ftcn]
prospective [resa]
Controlled [ftcn]
Trial [resa]
endpoints [qlco]
Macro [cnce]
Microangiopathy [dsyn]
diabetic [fndg]
Patients [podg]
